Feedback / Questions
mezagitamab (TAK-079) - Takeda
https://www.tipranks.com/news/company-announcements/takedas-phase-3-mezagitamab-trial-in-itp-moves-forward-keeping-pipeline-hopes-in-focus
Jan 28, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next